Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities. | Drugs Aging | 2023 | 37316689 | PubTator, text mining | PubMed |
| Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab. | Dermatol Ther (Heidelb) | 2023 | 37310643 | PubTator, text mining | PubMed |
| Cross talk between Paneth and tuft cells drives dysbiosis and inflammation in the gut mucosa. | Proc Natl Acad Sci U S A | 2023 | 37307458 | PubTator, text mining | PubMed |
| Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions. | Front Immunol | 2023 | 37304305 | PubTator, text mining | PubMed |
| Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique. | An Bras Dermatol | 2023 | 37302894 | PubTator, text mining | PubMed |
| Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells. | Front Oncol | 2023 | 37293587 | PubTator, text mining | PubMed |
| Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy. | Front Bioeng Biotechnol | 2023 | 37288355 | PubTator, text mining | PubMed |
| Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging. | J Transl Med | 2023 | 37286997 | PubTator, text mining | PubMed |
| Vaccinating against cancer: getting to prime time. | J Immunother Cancer | 2023 | 37286302 | PubTator, text mining | PubMed |
| Immuno-oncology-microbiome axis of gastrointestinal malignancy. | World J Gastrointest Oncol | 2023 | 37275452 | PubTator, text mining | PubMed |
| Barriers to overcoming immunotherapy resistance in glioblastoma. | Front Med (Lausanne) | 2023 | 37275361 | PubTator, text mining | PubMed |
| A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas. | Mater Today Bio | 2023 | 37273792 | PubTator, text mining | PubMed |
| Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis. | Am J Clin Dermatol | 2023 | 37266844 | PubTator, text mining | PubMed |
| Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight. | J Exp Med | 2023 | 37265457 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Updates in Leptomeningeal Disease. | Curr Oncol Rep | 2023 | 37256537 | PubTator, text mining | PubMed |
| From bench to bedside: the history and progress of CAR T cell therapy. | Front Immunol | 2023 | 37256141 | PubTator, text mining | PubMed |
| Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variables. | Front Immunol | 2023 | 37256133 | PubTator, text mining | PubMed |
| Collagen Fibril Orientation Instructs Fibroblast Differentiation Via Cell Contractility. | Adv Sci (Weinh) | 2023 | 37249413 | PubTator, text mining | PubMed |
| Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology. | Neoplasia | 2023 | 37244226 | PubTator, text mining | PubMed |
| Novel Therapeutic Targets for the Treatment of Atopic Dermatitis. | Biomedicines | 2023 | 37238974 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=19